Service & Suppliers

Found 24,259 articles

• Zafe Care Systems Places Order for the Pharmaceutical Robot Dosell

  12/2/2021

  iZafe Group AB - hereby announces that Zafe Care Systems is ordering 50 Dosell and is now initiating offensive marketing activities to bring the pharmaceutical robot to market.

• Discovery Life Sciences acquires In Vitro ADMET Laboratories

  12/2/2021

  Discovery Life Sciences™, the biospecimen and biomarker specialists™, announced that it has acquired In Vitro ADMET Laboratories to add the world's largest hepatocyte inventory and a world-renowned scientific leader to its growing company.

• OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™

  12/2/2021

  OpenEye Scientific and Specifica, Inc., announced they are releasing jointly developed software to help antibody engineers and bioinformaticians at pharmaceutical and biotechnology companies advance antibody discovery by identifying diverse antibody sets with better properties for downstream therapeutics development.

• Hillrom Shareholders Approve Acquisition By Baxter

  12/2/2021

  Hillrom announced that its shareholders have voted to approve the previously announced pending acquisition by Baxter International Inc. at a special meeting.

• QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19

  12/2/2021

  QIAGEN N.V. announced the CE marking of its QuantiFERON® SARS-CoV-2 assay that measures T-cell responses to SARS-CoV-2 and aids in the assessment of immunity in individuals who have received COVID-19 vaccination.

• ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

  12/2/2021

  ITM Isotope Technologies Munich SE and Navigo Proteins GmbH announced a research collaboration for the development of a fibroblast activation protein -targeted radiopharmaceutical program for the treatment of solid tumors.

• Danaher Announces Pricing Of Senior Notes Offering - Dec 02, 2021

  12/2/2021

  Danaher Corporation announced that it has priced an offering of $1,000,000,000 principal amount of 2.800% senior notes due 2051 at an offering price of 99.396% of the principal amount.

• Oxford Nanopore Announces Technology Updates - Dec 02, 2021

  12/2/2021

  Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 raw read and around Q30 Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that delivers the most accessible low-cost, high-output Oxford Nanopore sequencer

• 

  Human Skin Replaces Some Animal Testing, Expedites Drug Development

  12/1/2021

  Genoskin’s solution is to develop the technologies to replace animals and humans in clinical studies with virtual models, steadily pushing living creatures further and further from testing.

• NEOGEN Acquires Delf (UK) Ltd.

  12/1/2021

  NEOGEN Corporation announced that it has acquired Delf Ltd., a United Kingdom-based manufacturer and supplier of animal hygiene and industrial cleaning products.

• Philips expands Augmented Reality Surgical Navigation – ClarifEye – to two new international sites with successful clinical outcomes

  12/1/2021

  Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced that the first patients have been successfully treated using its innovative 3D Augmented Reality spine navigation solution at Sant Joan de Déu Barcelona Children's Hospital, Spain, and the Armed Forces Hospital, Oman.

• MITRE Names Chris Fall as New Vice President of Applied Sciences, MITRE Labs

  12/1/2021

  MITRE appointed Chris Fall as its vice president of applied sciences, a new function within MITRE Labs to lead core research and development in emerging technology domains including quantum computing, material science, synthetic biology, and space.

• Notable and CicloMed Initiate Phase 1B/2A Clinical Trial of Fosciclopirox in Acute Myelogenous Leukemia Under Co-Development Agreement

  12/1/2021

  Notable Labs, Inc., a clinical-stage predictive precision therapeutics company and CicloMed LLC, a developmental-stage pharmaceutical company have initiated a Phase 1B/2A clinical trial of fosciclopirox in patients with refractory acute myelogenous leukemia under the terms of a co-development agreement.

• Innovative Gaumard Ultrasound™ and Pediatric Emergency POCUS/eFAST Scenario Courseware Named 2021 EMS World Innovation Awards Winner

  12/1/2021

    [01-December-2021]   MIAMI , Dec. 1, 2021 /PRNewswire/ -- Gaumard Scientific Co., an industry leader of simulation technology for healthcare education and training, today announced that the company's  Ultrasound and Pediatric Emergency POCUS/eFAST Scenario Courseware is honored as a 2021 EMS World Innovation Awards Winner.

• MedMira Reports FY2021 Fourth Quarter and Year End Financial Results

  12/1/2021

  MedMira Inc., reported on its financial results for the financial year ended July 31, 2021.

• Nikon introduces the new AX R MP multiphoton confocal microscope

  12/1/2021

  Nikon Instruments Inc., innovator of advanced microscope systems announced the release of the AX R MP multiphoton confocal microscope, which can acquire high resolution, large field of view images, deep within living organisms at high speed.

• Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B

  12/1/2021

  Eurofins Technologies announces the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV.

• Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific

  12/1/2021

  Amcor, a global leader in developing and producing responsible packaging, announced the opening of its greenfield packaging facility in Tuas, Singapore.

• Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises

  11/30/2021

  Rapid Dose Therapeutics Corp. has entered into a strategic business development agreement with AB Strategic Ventures (“ ABSV ”) with the purpose of supporting relationship building with First Nations business enterprises through the fulfillment and sale of products made by Indigenous people to markets across Canada.

• New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genome Editing

  11/30/2021

  For research applications requiring highly precise genome editing, including engineering CAR T cells and creating cellular models for disease discovery, the Invitrogen TrueCut HiFi Cas9 Protein* significantly minimizes off-target events while retaining maximum on-target editing efficiency.